Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$26.3B
972M shares
52-week range
$22.90 – $32.24
46% from low
Exchange
NYSE
CS
Borrow rate
1.95%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.12B | $17.15B | $17.31B | $17.16B | $17.83B | $18.17B | $18.02B | $17.83B |
| Cost of revenue | $9.57B | $9.20B | $9.40B | $9.99B | $10.63B | $10.72B | $10.25B | $9.78B |
| Gross profit | $8.55B | $7.95B | $7.91B | $7.17B | $7.19B | $7.45B | $7.77B | $8.06B |
| Gross margin | 47.2% | 46.4% | 45.7% | 41.8% | 40.4% | 41.0% | 43.1% | 45.2% |
| R&D | $1.76B | $1.79B | $1.91B | $1.81B | $2.09B | $1.89B | $1.75B | $1.70B |
| Operating income | $1.72B | $1.37B | $1.26B | $553.0M | −$1.53B | −$115.0M | $529.0M | $1.42B |
| EBITDA | $2.79B | $2.62B | $2.75B | $2.00B | $115.0M | $1.04B | $1.85B | $2.64B |
| Net income | $1.09B | $1.17B | $1.19B | $3.32B | −$1.61B | −$466.0M | −$702.0M | $895.0M |
| Net margin | 6.0% | 6.8% | 6.9% | 19.3% | -9.0% | -2.6% | -3.9% | 5.0% |
| EPS (diluted) | 1.09 | 1.20 | 1.23 | 0.64 | -1.68 | -0.49 | -0.75 | 0.93 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $18.3B | $1.56 | $1.35–$1.83 | 3 |
| 2027 | $19.1B | $1.74 | $1.52–$2.06 | 3 |
| 2028 | $19.9B | $1.93 | $1.86–$2.08 | 1 |
| 2029 | $20.9B | $2.05 | $1.97–$2.20 | 1 |
Forward consensus · source: Financial Modeling Prep
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
www.philips.comNo one on the platform currently holds PHG.
No tracked institution reports a position in PHG as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-13 | $0.9900 | 2026-06-03 |
| 2025-05-13 | $0.9673 | 2025-06-06 |
| Execution date | Ratio |
|---|---|
| 2026-05-13 | 1.037127656-for-1 |
| 2025-05-13 | 1.0423095962-for-1 |
| 2024-05-09 | 1.03416654-for-1 |
| 2023-05-11 | 1.0446616-for-1 |
| 2022-05-12 | 1.0366053648-for-1 |
No one on the platform has traded PHG yet.
| $25.8B |
| — |
| NTRANatera, Inc. | $271.45 | -0.32% | $38.9B | — |
| PODDInsulet Corp. | $152.25 | -3.48% | $10.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at 1.4× sales vs its 1.2× historical median P/S.
Fair value ≈ $23.30 · price $27.19 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$PHG Current Stock Price: $26.73 Contracts to trade: $27.0 PHG Jul 17 2026 Call Entry: $0.65 Exit: $1.13 ROI: 75% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗$PHG Share Price: $26.95 Contract Selected: Jan 15, 2027 $26.0 Calls Buy Zone: $2.89 – $3.57 Target Zone: $5.17 – $6.32 Potential Upside: 69% ROI Time to Expiration: 234 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$PHG Price: $27.05 (+2.27%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.79% RSI: 39.0 | Momentum: Strong Downside Volume: -71.4% vs avg Volatility: 2.12% Support: $25.10 | Resistance: $29.95 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
View on StockTwits ↗$PHG just rolled out a CT scanner built for speed. The new Rembra system can deliver 106 images per second and up to 270 scans daily, helping hospitals handle heavy imaging demand and accelerate diagnostics. See what this launch could mean for the company🏥📈 https://www.zacks.com/stock/news/2880446/philips-unveils-rembra-ct-scanner-to-speed-up-medical-imaging?cid=sm-stocktwits-2-2880446-teaser-36484&ADID=SYND_STOCKTWITS_TWEET_2_2880446_TEASER_36484
View on StockTwits ↗$PHG outperforms the Medical sector, up 7.6% in a year! 🚀 📊 Strong demand & higher order intake drive growth 🩺 New Rembra CT system boosts hospital capabilities 🌟 Personal health segment shines Discover Philips' bullish outlook for 2026 here 👉 https://www.zacks.com/stock/news/2880446/philips-unveils-rembra-ct-scanner-to-speed-up-medical-imaging?cid=sm-stocktwits-2-2880446-body-36466&ADID=SYND_STOCKTWITS_TWEET_2_2880446_BODY_36466
View on StockTwits ↗Philips $PHG Q4 earnings: Solid growth but margin contraction hits hard 📉 👎 Gross margin down 600 bps YoY to 44.9% 📉 3.46% drop in pre-market trading 📈 7% YoY growth in comparable sales See the full breakdown here 👉 https://www.zacks.com/stock/news/2855154/philips-posts-earnings-in-q4-revenues-increase-yy-shares-dip?cid=sm-stocktwits-2-2855154-body-33128&ADID=SYND_STOCKTWITS_TWEET_2_2855154_BODY_33128
View on StockTwits ↗$PHG swings to profit… but the stock still drops? 🤔 Q4 delivered a return to profitability, comparable sales up 7%, orders rising, and double-digit EBITA growth — plus a 2026 outlook on the table. Yet shares dipped. Is this a classic sell-the-news move or is the market seeing something you’re not? Full breakdown here 👉 https://www.zacks.com/stock/news/2855154/philips-posts-earnings-in-q4-revenues-increase-yy-shares-dip?cid=sm-stocktwits-2-2855154-teaser-33127&ADID=SYND_STOCKTWITS_TWEET_2_2855154_TEASER_33127
View on StockTwits ↗$PHG 1W momentum is accelerating with 1D RSI at 61. 4H CCI shows overbought conditions, but 30M STOCH indicates buyers are still defending the trend. Expect volatility near current multi-period resistance levels. @DailyAnalysis
View on StockTwits ↗$PHG Buyers remain active as price moves higher. Pullbacks are being bought. Momentum remains bullish.
View on StockTwits ↗$PHG Wakey Wakey… News! https://www.benzinga.com/node/50322932
View on StockTwits ↗$PHG Did I miss something that caused this 10% run up over the past few weeks?
View on StockTwits ↗$FTS $PPL $NTRS $DXCM $PHG Very strong summary
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.